Nitrogen Mustard Based 2-Benzylidene-1-tetralone as ICT-Based Fluorescent Probe for Drug Release Monitoring and Cervical Cancer Therapy
Yuanwei Lianga, Chengpeng Lia, Wenhua Qiua, Puwang Lib, Ziming Yangb, Haisheng Linc, d, *, and Yuntao Zhaoc, d, **
aCollege of Chemistry and Environment, Guangdong Ocean University, Zhanjiang, 524088 China
bAgricultural Product Processing Research Institute, Chinese Academy of Tropical Agricultural Sciences, Zhanjiang, 524001 China
cCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang, 524088 China
dGuangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Zhanjiang, 524088 China
email: *haishenglin@163.com
email: **zhaoyt@gdou.edu.cn
Received 30 July, 2022
Abstract—
A series of novel intramolecular charge transfer (ICT) based 2-benzylidene-1-tetralones that contain nitrogen mustard for drug release monitoring and cervical cancer therapy were developed. Their emission wavelength and Stokes shift were up to 550 nm and 142 nm, respectively. These compounds exerted excellent anticancer activity against cervical cancer cells, among which 2-{4-[bis(2-chloroethyl)amino]benzylidene}-7-fluoro-3,4-dihydronaphthalen-1(2H)-one exerted the strongest anti-proliferation activity that inhibited HeLa cell cycle in G2/M phase and induced cell apoptosis, as well as activating pro-apoptotic proteins. Furthermore, the release of 2-{4-[bis(2-chloroethyl)amino]benzylidene}-7-fluoro-3,4-dihydronaphthalen-1(2H)-one probe was monitored to locate in lysosomes and nuclei.
Keywords:
nitrogen mustard,
drug release,
fluorescent probe,
cancer therapy
DOI: 10.1134/S1070363222110433